Smith Brigitte 4
4 · KALOBIOS PHARMACEUTICALS INC · Filed Feb 4, 2013
Insider Transaction Report
Form 4
Smith Brigitte
Director
Transactions
- Purchase
Common Stock
2013-01-31$8.00/sh+25,000$200,000→ 25,000 total(indirect: By GBS Bioventures II A/C)
Footnotes (1)
- [F1]Represents securities held directly by GBS Bioventures II A/C ("Bioventures"). The Reporting Person is a managing director of GBS Venture Partners Pty Ltd which manages Bioventures. The Reporting Person shares voting and investment power with another partner and may be deemed to be an indirect beneficial owner of the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.